OBJECTIVE: To assess a possible relationship between thyroid-stimulating hormone (TSH) levels, vascular risk factors, and Alzheimer disease (AD). METHODS: TSH levels were measured in 178 AD patients (35 confirmed post mortem) and 291 cognitively screened control subjects who were all euthyroid (TSH: 0.5 to 6 mU/L). The risk of AD was determined in participants with lower levels of TSH, several cerebrovascular risk factors, and other potential confounds. RESULTS: AD patients had significantly lower levels of TSH than control subjects. Lowered TSH was associated with a more than twofold increased risk of AD (odds ratio = 2.36, 95% CI = 1.19 to 4.67), independent of other risk factors. CONCLUSION: Lowered TSH within the normal range is a risk factor for AD, independent of several cerebrovascular risk factors and confounding variables.
OBJECTIVE: To assess a possible relationship between thyroid-stimulating hormone (TSH) levels, vascular risk factors, and Alzheimer disease (AD). METHODS:TSH levels were measured in 178 ADpatients (35 confirmed post mortem) and 291 cognitively screened control subjects who were all euthyroid (TSH: 0.5 to 6 mU/L). The risk of AD was determined in participants with lower levels of TSH, several cerebrovascular risk factors, and other potential confounds. RESULTS:ADpatients had significantly lower levels of TSH than control subjects. Lowered TSH was associated with a more than twofold increased risk of AD (odds ratio = 2.36, 95% CI = 1.19 to 4.67), independent of other risk factors. CONCLUSION: Lowered TSH within the normal range is a risk factor for AD, independent of several cerebrovascular risk factors and confounding variables.
Authors: Jennifer Duncan Davis; Anna Podolanczuk; John E Donahue; Edward Stopa; James V Hennessey; Lu-Guong Luo; Yow-Pin Lim; Robert A Stern Journal: Curr Aging Sci Date: 2008-12
Authors: T Juárez-Cedillo; L Basurto-Acevedo; S Vega-García; A Sánchez-Rodríguez Martha; R Retana-Ugalde; E Juárez-Cedillo; C Gonzalez-Melendez Roberto; J Escobedo-de-la-Peña Journal: J Endocrinol Invest Date: 2017-03-25 Impact factor: 4.256
Authors: Russell T Joffe; Elizabeth N Pearce; James V Hennessey; Joseph J Ryan; Robert A Stern Journal: Int J Geriatr Psychiatry Date: 2012-03-13 Impact factor: 3.485
Authors: Frank Jan de Jong; Kamal Masaki; Hepei Chen; Alan T Remaley; Monique M B Breteler; Helen Petrovitch; Lon R White; Lenore J Launer Journal: Neurobiol Aging Date: 2007-09-17 Impact factor: 4.673
Authors: Zaldy S Tan; Alexa Beiser; Ramachandran S Vasan; Rhoda Au; Sanford Auerbach; Douglas P Kiel; Philip A Wolf; Sudha Seshadri Journal: Arch Intern Med Date: 2008-07-28
Authors: Carole Rieben; Daniel Segna; Bruno R da Costa; Tinh-Hai Collet; Layal Chaker; Carole E Aubert; Christine Baumgartner; Osvaldo P Almeida; Eef Hogervorst; Stella Trompet; Kamal Masaki; Simon P Mooijaart; Jacobijn Gussekloo; Robin P Peeters; Douglas C Bauer; Drahomir Aujesky; Nicolas Rodondi Journal: J Clin Endocrinol Metab Date: 2016-09-30 Impact factor: 5.958